Literature DB >> 27134667

Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials.

Shira Zelber-Sagi1, Justyna Godos2, Federico Salomone3.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is emerging as a major public health problem because of its association with increased cardiovascular and liver-related morbidity and mortality. Both genetic factors and lifestyle contribute to the pathogenesis of NAFLD. Lifestyle, including dietary habits and physical activity, is a modifiable risk factor and thus represents the main target for the prevention and treatment of NAFLD. In this review, we summarize the evidence regarding nutritional aspects (i.e. total energy intake, saturated fat and carbohydrates intake, certain foods or drinks and dietary patterns as a whole) in the treatment of NAFLD. In addition, we analyze the evidence concerning the independent effect of physical activity, including aerobic and resistance training, in the treatment of NAFLD. A therapeutic algorithm according to results from intervention trials is also provided for clinicians and other healthcare professionals involved in the management of NAFLD.

Entities:  

Keywords:  coffee; diet; lifestyle; nonalcoholic fatty liver disease; physical activity

Year:  2016        PMID: 27134667      PMCID: PMC4830109          DOI: 10.1177/1756283X16638830

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN: 1756-283X            Impact factor:   4.409


  137 in total

Review 1.  The liver X receptor gene team: potential new players in atherosclerosis.

Authors:  Joyce J Repa; David J Mangelsdorf
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

Review 2.  Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review.

Authors:  Christian Thoma; Christopher P Day; Michael I Trenell
Journal:  J Hepatol       Date:  2011-07-01       Impact factor: 25.083

3.  Effect of diet on lipid metabolism in experimental animals and man.

Authors:  R H Herman; D Zakim; F B Stifel
Journal:  Fed Proc       Date:  1970 May-Jun

Review 4.  Genetic-related and carbohydrate-related factors affecting liver fat accumulation.

Authors:  Michael I Goran; Ryan Walker; Hooman Allayee
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-07       Impact factor: 4.294

5.  Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults.

Authors:  Marno Celeste Ryan; Fahim Abbasi; Cindy Lamendola; Susan Carter; Tracey Lynn McLaughlin
Journal:  Diabetes Care       Date:  2007-03-10       Impact factor: 19.112

6.  The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the Hertfordshire Cohort Study: a randomised controlled trial.

Authors:  F M Finucane; S J Sharp; L R Purslow; K Horton; J Horton; D B Savage; S Brage; H Besson; E De Lucia Rolfe; A Sleigh; H J Martin; A Aihie Sayer; C Cooper; U Ekelund; S J Griffin; N J Wareham
Journal:  Diabetologia       Date:  2010-01-06       Impact factor: 10.122

7.  Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes.

Authors:  Mariana Lazo; Steven F Solga; Alena Horska; Susanne Bonekamp; Anna Mae Diehl; Frederick L Brancati; Lynne E Wagenknecht; F Xavier Pi-Sunyer; Steven E Kahn; Jeanne M Clark
Journal:  Diabetes Care       Date:  2010-07-27       Impact factor: 19.112

8.  Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction.

Authors:  Erik Kirk; Dominic N Reeds; Brian N Finck; S Mitra Mayurranjan; Mitra S Mayurranjan; Bruce W Patterson; Samuel Klein
Journal:  Gastroenterology       Date:  2009-01-25       Impact factor: 22.682

9.  Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men.

Authors:  M A Banerji; N Faridi; R Atluri; R L Chaiken; H E Lebovitz
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

10.  Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients.

Authors:  Lutgarda Bozzetto; Anna Prinster; Giovanni Annuzzi; Lucia Costagliola; Anna Mangione; Alessandra Vitelli; Raffaella Mazzarella; Margaret Longobardo; Marcello Mancini; Carlo Vigorito; Gabriele Riccardi; Angela A Rivellese
Journal:  Diabetes Care       Date:  2012-07       Impact factor: 19.112

View more
  42 in total

1.  Diet Associations With Nonalcoholic Fatty Liver Disease in an Ethnically Diverse Population: The Multiethnic Cohort.

Authors:  Mazen Noureddin; Shira Zelber-Sagi; Lynne R Wilkens; Jacqueline Porcel; Carol J Boushey; Loïc Le Marchand; Hugo R Rosen; Veronica Wendy Setiawan
Journal:  Hepatology       Date:  2020-02-14       Impact factor: 17.425

2.  Pharmacologic Management of Nonalcoholic Steatohepatitis.

Authors:  Brent A Neuschwander-Tetri
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-10

3.  Sex-Specific Metabolite Biomarkers of NAFLD in Youth: A Prospective Study in the EPOCH Cohort.

Authors:  Wei Perng; Ellen C Francis; Harry A Smith; John Carey; Dongqing Wang; Katerina M Kechris; Dana Dabelea
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

4.  Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation.

Authors:  Jaividhya Dasarathy; Rony Varghese; Abram Feldman; Amer Khiyami; Arthur J McCullough; Srinivasan Dasarathy
Journal:  J Nutr       Date:  2017-08-16       Impact factor: 4.798

5.  Betulinic acid alleviates endoplasmic reticulum stress-mediated nonalcoholic fatty liver disease through activation of farnesoid X receptors in mice.

Authors:  Ming Gu; Ping Zhao; Shiying Zhang; Shengjie Fan; Li Yang; Qingchun Tong; Guang Ji; Cheng Huang
Journal:  Br J Pharmacol       Date:  2019-03-18       Impact factor: 8.739

Review 6.  Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives.

Authors:  Christina-Maria Flessa; Ioannis Kyrou; Narjes Nasiri-Ansari; Gregory Kaltsas; Athanasios G Papavassiliou; Eva Kassi; Harpal S Randeva
Journal:  Curr Obes Rep       Date:  2021-03-22

7.  Effects of Calorie Restricted Diet on Oxidative/Antioxidative Status Biomarkers and Serum Fibroblast Growth Factor 21 Levels in Nonalcoholic Fatty Liver Disease Patients: A Randomized, Controlled Clinical Trial.

Authors:  Somayyeh Asghari; Mahsa Rezaei; Maryam Rafraf; Mahdiyeh Taghizadeh; Mohammad Asghari-Jafarabadi; Maryam Ebadi
Journal:  Nutrients       Date:  2022-06-16       Impact factor: 6.706

8.  Lifestyle weight-loss intervention may attenuate methylation aging: the CENTRAL MRI randomized controlled trial.

Authors:  Anat Yaskolka Meir; Maria Keller; Stephan H Bernhart; Ehud Rinott; Gal Tsaban; Hila Zelicha; Alon Kaplan; Dan Schwarzfuchs; Ilan Shelef; Yftach Gepner; Jun Li; Yifei Lin; Matthias Blüher; Uta Ceglarek; Michael Stumvoll; Peter F Stadler; Meir J Stampfer; Peter Kovacs; Liming Liang; Iris Shai
Journal:  Clin Epigenetics       Date:  2021-03-04       Impact factor: 6.551

9.  Associations between Dietary Nutrient Intakes and Hepatic Lipid Contents in NAFLD Patients Quantified by ¹H-MRS and Dual-Echo MRI.

Authors:  Yipeng Cheng; Kewei Zhang; Yang Chen; Yanchuan Li; Yuzheng Li; Kuang Fu; Rennan Feng
Journal:  Nutrients       Date:  2016-08-27       Impact factor: 5.717

10.  Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation.

Authors:  Jia-Hung Ye; Jung Chao; Ming-Ling Chang; Wen-Huang Peng; Hao-Yuan Cheng; Jiunn-Wang Liao; Li-Heng Pao
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.